Among the three groups, Xia Yu's group was responsible for conquering the Coller Perkins Company, which had the strongest relationship with Professor Herb Boyle.

Although Kleelle Perkins has invested in Genentech three times and seems to have always supported Professor Herb Boyle, Xia Yu doesn't care.

Weak strength is the Achilles' heel of Colele Perkins, and a venture capital company with a strength like it generally invests in angel rounds or A rounds, and it is already the limit to be able to follow in B rounds.

Genentech was pushed to go public and was not in Series C financing, so there was no possibility that they would be behind it.

For example, Genentech is valued at more than 100 million at this time, and if it starts Series C financing, 10% of the equity needs at least 10 million US dollars, or even more.

With the strength of the Colele Perkins company, it is difficult to keep up, after all, the company's operating capital does not exceed 50 million US dollars, and it is impossible to invest only in the project of Genentech, so the company's liquidity will definitely not be much.

Genentech's valuation is high enough that pushing it to go public and letting public capital take the risk is the best way to do it, and Koller Perkins will be able to untie the profits and use the huge profits to invest in new start-up companies, so as to grow in a cycle.

Because they had made an appointment in advance, Xia Yu and others were led by the reception staff to meet Harry Morrison, CEO of Colele Perkins, and two other executives.

Seeing that Xia Yu's team of five people, but with a young yellow race as the core, Harry Morrison's eyes froze, and several thoughts flashed in his heart.

For Polaris Capital, Harry Morrison had never heard of it before, that is, when he was made an appointment yesterday, he inquired about it, and he didn't get much news, only that it was a newly established company.

But he did not doubt the strength of Polaris Capital, because according to his investigation, Polaris Capital bought a 30-story office building in downtown San Francisco.

Anyway, with the strength of their Colele Perkins company, they definitely don't have the spare money to buy an office building!

Therefore, he has a cautious and even vigilant attitude towards Polaris Capital, whose origin is unknown.

This kind of company with a mysterious background is best not to be offended!

Harry Morrison's true attitude did not show, he warmly beckoned Xia Yu and the others to sit down, and after his subordinates poured tea and coffee for everyone one by one, he drank coffee and chatted with Xia Yu.

"Mr. Xia, it's an honor to meet you, welcome to you!"

"Thank you, Mr. Morrison, for your hospitality!"

......

"Mr. Xia, I don't know what I can do for you this time?" asked Harry Morrison after the greetings, looking at Xia Yu tightly.

Xia Yu smiled slightly and said: "I came to disturb this time, mainly to do your company a favor, of course, I tell the truth, it is also beneficial to us, it is a win-win situation." ”

Harry Morrison sighed undeniably, but his heart was more vigilant, he didn't believe in such a good thing, he then asked, "I don't know what it is?"

Xia Yu smiled and said bluntly: "Actually, I want to acquire the equity of Genentech held by your company. ”

Harry Morrison's face changed suddenly, and before he could speak, a middle-aged white man in his thirties next to him said in a resolute tone: "Impossible, Genentech's equity is not for sale in our company!"

Seeing what the person next to him said, Harry Morrison's face softened a little, but his tone was also cold, and he seemed to leave no room for it, refusing: "I'm sorry, Mr. Xia, we can't meet your request!"

Xia Yu stopped the subordinates who wanted to speak, looked indifferent, looked at the person who spoke first with a smile, and asked, "This gentleman, can I have the honor to know your name?"

Xia Yu's attitude was very friendly, so the white middle-aged man's face softened slightly, and he spit out a few words: "Robert Swanson!"

Xia Yu suddenly realized, it turned out to be the one who unearthed Genentech, no wonder the reaction was so fierce.

With his achievements in discovering Genentech, it is normal for him to become a senior partner of Colele Perkins, so it is no wonder that he can accompany Harry Morrison.

Xia Yu said with a smile: "Mr. Swanson, and Mr. Morrison, in fact, you don't need to refuse so quickly, there is nothing in the world that cannot be sold, the key is whether the price can be satisfied, I haven't bid yet, why do you refuse so quickly?"

"Maybe my price will satisfy you?"

Harry Morrison and Robert Swanson looked at each other, and both saw the surprise in each other's eyes.

After Robert Swanson made eye contact with Harry Morrison, he said with a cold expression: "Mr. Xia, Genentech is now going through the process of going public, and it will be listed in half a year at most, and its market value will definitely be several times higher than the current valuation at that time, why should we pick the fruit in advance?"

Xia Yu shook his head and argued: "It's hard to say if it's several times higher, because so far, Genentech has not made a profit, and no one knows how the capital market will choose, maybe it will fall below the issue price?"

Robert Swanson is not a fuel-efficient lamp, he directly grabbed Xia Yu's sore foot, and retorted strongly: "It will definitely not fall below the issue price!" Maybe I wasn't sure how the capital market would choose before, but today you are here, our confidence has been strengthened, and I believe that Genentech will definitely be able to successfully go public, and the stock price will greatly exceed the opening price!"

Well, Xia Yu's statement was directly blocked by Robert Swanson.

But Xia Yu had already prepared well before he came, and the reasons for the negotiation had already been thought of a lot.

He didn't admit Robert Swanson's statement, directly ignored it, and opened another battlefield and said: "Mr. Swanson, if it takes half a year, Genentech can be listed, but your original equity will be locked for one year before it can be unlocked for trading, which means that at least one and a half years, your funds will be locked, even if Genentech's stock price is high, you can't cash out." ”

"At the current speed of technological development, in this year and a half, there will be countless companies with strong potential, are you willing to miss out on financial reasons?"

Weakness is the Achilles' heel, and if the company has strong capital, Xia Yu's reason is simply untenable.

But saying it now makes Harry Morrison and Robert Swanson and others look ugly.

At this time, another middle-aged man, Colin Hicks, who had been sitting silently, defended himself: "Mr. Xia, you don't have to worry about this, we can afford to wait for half a year, Genentech is listed, even if our original shares are locked, we can also use equity pledges to find bank loans." ”

"And I believe that as long as Genentech goes public, there will be a steady stream of investors waving dollars to invest in us. ”

Xia Yu said with a smile: "It's hard to say whether there will be investors who come to the door, after all, it hasn't happened yet, I'll just say one thing, you want to use Genentech equity pledge loan, and the precondition is that Genentech is successfully listed." ”

"And then, you are also very aware of the conservative nature of the banks, they like the stocks of companies listed on the New York Stock Exchange, and they don't approve of the stocks of the NASDAQ, otherwise there would be no venture capital market. “

"Even if you find a bank that is willing to pledge the loan, the loan ratio is four or five tiers, after all, for the bank, the negative profit and high stock price of Nasdaq stock is too risky. ”

"With so much risk, you still need to pay the bank high interest rates, what if one day Genentech's stock price plummets, or you don't find new potential companies?"

Xia Yu's statement, the three people who spoke were speechless, and they didn't know how to refute it.

PS: Ask for a ticket book subscription!

()